Dr. Andersson has served as a member of our board of directors since December 2016. Dr. Andersson joined Sunstone Life Science Ventures, a venture capital firm, in April 2005 and has served as a General Partner there since July 2011. He actively manages investments in the biopharmaceutical industry focusing on oncology, cardiology and nucleotide modalities. He serves on the board of directors of several private life sciences companies including Cantargia AB and Forendo Pharma Ltd. Dr. Andersson received his M.Sc. in Chemical Engineering from the Technical University of Denmark and completed his Ph.D. in Mathematical Statistics from the University of Copenhagen and Humboldt University in Berlin.
Claus Andersson, Ph.D.
Member - Sunstone Life Science Ventures